Patent ID: 7407942
Filing Date: 2008-08-05
Classification: C07H

Abstract:
1. Compounds represented by formula (I): or the pharmaceutically acceptable salts, esters and prodrugs thereof, wherein R  R when R alternatively, R X and Y are: a) when one of X and Y is a hydrogen, the other is selected from: b) X, Y taken together with the carbon atom to which they are attached is: B is NR 30 R 40 ; wherein R 30 and R 40 is independently selected from the group consisting of hydrogen, acyl, a substituted or unsubstituted, saturated or unsaturated aliphatic group, a substituted or unsubstituted, saturated or unsaturated alicyclic group, a substituted or unsubstituted aromatic group, a substituted or unsubstituted heteroaromatic group, saturated or unsaturated heterocyclic group; or can be taken together with the nitrogen atom to which they are attached to form a substituted or unsubstituted heterocyclic or heteroaromatic ring; V is selected from the group consisting of hydrogen, azido, cyano, nitro, aldehyde, carboxylic acid, amide, a substituted or unsubstituted, saturated or unsaturated aliphatic group; Q is selected from the group consisting of: (a) hydrogen; (b) protected hydroxy; and (c) OR L is selected from the group consisting of: (a) —CH (b) —CH(OH)CH (c) —C Rx is hydrogen, hydroxy protecting group or hydroxy prodrug group.